Novel Discoveries of the Relationship Between the Vitreous Zonule and the Anterior Segment Characteristics in Eyes With Primary Angle-Closure Disease.
Journal
Investigative ophthalmology & visual science
ISSN: 1552-5783
Titre abrégé: Invest Ophthalmol Vis Sci
Pays: United States
ID NLM: 7703701
Informations de publication
Date de publication:
01 12 2022
01 12 2022
Historique:
entrez:
15
12
2022
pubmed:
16
12
2022
medline:
20
12
2022
Statut:
ppublish
Résumé
To investigate the presence of the vitreous zonule (VZ) in different subtypes of primary angle-closure disease (PACD) and to explore the relationship between VZ and anterior chamber angle characteristics. Patients with clinical diagnoses of acute primary angle-closure (PAC)/PAC glaucoma (APAC[G]) or chronic PAC/PAC glaucoma (CPAC[G]) and healthy subjects were enrolled. A total of 300 eyes of 180 subjects were included. Anterior segment parameters and the presence of the VZ were assessed by ultrasound biomicroscopy. The presence of VZ was compared among different subtypes of PACD. Anterior segment parameters were compared between eyes in vitreous zonule group (VZG) and no vitreous zonule group (NVZG). Logistic regression analysis was conducted to identify factors associated with the presence of VZ. APAC(G) eyes had lower VZ presence compared to the fellow eyes of APAC(G) (P < 0.001). VZ was more likely to be seen in the eyes of healthy subjects and PAC suspect than in the eyes of PAC and PAC glaucoma (PACG) (P < 0.05). NVZG had shorter angle opening distance 500/750 (P < 0.001), smaller trabecular iris angle 500/750 (P < 0.001), smaller trabecular-iris space area 500/750 (P < 0.001), smaller trabecular-ciliary angle (P = 0.009), smaller iris area (P = 0.010), and greater lens vault (P = 0.004) compared to VZG. Greater lens vault (LV) was independently associated with absence of VZ (odds ratio = 0.253; 95% confidence interval, 0.109-0.586; P = 0.001). VZ was less likely to be observed in PAC/PACG eyes. PACD eyes with less VZ had narrower angle, more anteriorly rotated ciliary body, and greater LV.
Identifiants
pubmed: 36520454
pii: 2783926
doi: 10.1167/iovs.63.13.16
pmc: PMC9769030
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
16Commentaires et corrections
Type : ErratumIn
Références
Ophthalmic Physiol Opt. 2016 Jan;36(1):21-32
pubmed: 26769326
Ophthalmology. 2010 Oct;117(10):1967-73
pubmed: 20541809
J Glaucoma. 2015 Mar;24(3):233-7
pubmed: 25055211
Invest Ophthalmol Vis Sci. 2014 May 20;55(6):3646-50
pubmed: 24845639
Invest Ophthalmol Vis Sci. 2013 Jul 26;54(7):5049-58
pubmed: 23745005
Optom Vis Sci. 2001 Jun;78(6):417-24
pubmed: 11444631
Ophthalmology. 2014 Nov;121(11):2081-90
pubmed: 24974815
Br J Ophthalmol. 2002 Feb;86(2):238-42
pubmed: 11815354
J Glaucoma. 2011 Jun-Jul;20(5):315-8
pubmed: 20577108
Arch Ophthalmol. 1993 Sep;111(9):1263-9
pubmed: 8363470
Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1801-1812
pubmed: 31038661
Invest Ophthalmol Vis Sci. 2013 Jul 26;54(7):5035-48
pubmed: 23745002
Br J Ophthalmol. 1964 Oct;48:544-50
pubmed: 14221777
Prog Retin Eye Res. 2017 Mar;57:26-45
pubmed: 28039061
PLoS One. 2018 Feb 15;13(2):e0193006
pubmed: 29447247
Clin Exp Ophthalmol. 2012 Nov;40(8):792-801
pubmed: 22594402
Am J Ophthalmol. 2013 Apr;155(4):664-673, 673.e1
pubmed: 23246271
Br J Ophthalmol. 2006 Mar;90(3):262-7
pubmed: 16488940
Semin Ophthalmol. 2018;33(5):595-601
pubmed: 29185835
Invest Ophthalmol Vis Sci. 2021 Nov 1;62(14):6
pubmed: 34730791
Ophthalmology. 1998 Nov;105(11):2091-8
pubmed: 9818611
Invest Ophthalmol Vis Sci. 2010 Mar;51(3):1554-64
pubmed: 19815737
J Glaucoma. 2019 Dec;28(12):1048-1053
pubmed: 31633619
Am J Ophthalmol. 2009 Nov;148(5):657-669.e1
pubmed: 19878757